<DOC>
<DOCNO>EP-1094074</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Radioactively-labeled somatostatin derived peptides for imaging and therapeutic uses
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3800	A61K3800	C07K14435	C07K14655	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	C07K	C07K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K38	A61K38	C07K14	C07K14	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
This invention relates to therapeutic reagents and peptides, radiodiagnostic reagents and
peptides, and methods for producing labeled radiodiagnostic agents. Specifically, the

invention relates to peptide derivatives and analogs of somatostatin, and embodiments
of such peptides labeled with technetium-99m (Tc-99m), as well as methods and kits for

making, radiolabeling and using such peptides to image sites in a mammalian body.
The invention also relatees to peptide derivatives and analogues of somatostantin

labeled with rhenium-186 (
186
Re) and rhenium-188 (
188
Re), and methods and kits for
making, radiolabeling and using such peptides therapeutically in a mammalian body.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
DIATIDE INC
</APPLICANT-NAME>
<APPLICANT-NAME>
DIATIDE, INC.
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
DEAN RICHARD T
</INVENTOR-NAME>
<INVENTOR-NAME>
LISTER-JAMES JOHN
</INVENTOR-NAME>
<INVENTOR-NAME>
DEAN, RICHARD T.
</INVENTOR-NAME>
<INVENTOR-NAME>
LISTER-JAMES, JOHN
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
